Clinical Trials Browser

Has results × Carcinoma, Endometrioid × cabozantinib × Clear all

NCT01935934 2025-10-01

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Phase 2 Completed

102 enrolled 14 charts

Carcinoma, Endometrioid